• 4 min read Small But Mighty Lab Device Could Transform NASA Research NASA Science Editorial Team Contents Potential to speed up access to research results Shining light on space biology Testing commercial lab equipment using ultimate laboratory A small but mighty piece of lab equipment, about the size of a cellphone, has arrived at the International Space Station after launching with NASA’sSpaceX Crew-12 mission. • NASA aims to use the off-the-shelf device, called a microplate reader, to conduct vital biological research in space and get real-time access to data. • Demonstrations like this are part of NASA’sCommercially Enabled Rapid Space Science (CERISS) initiative, which partners with industry to develop transformative research capabilities and increase the pace and productivity of space science. • NASA’sBiological and Physical Sciences Divisionis leading the demonstration in collaboration with the agency’sInternational Space StationProgram. • Potential to speed up access to research results The immediate benefit of using a microplate reader for space science is speed. • Scientists can get data as soon as testing is complete, rather than waiting for samples to be stored, returned to Earth, and analyzed in ground labs.

Article Summaries:

  • NASA has delivered a cellphone‑sized microplate reader to the International Space Station aboard the SpaceX Crew‑12 mission. The off‑the‑shelf device, part of the Commercially Enabled Rapid Space Science (CERISS) program, will enable in‑situ biological assays, providing immediate data rather than waiting for sample return. Initial tests will use samples from the Microgravity Associated Bone Loss‑B (MABL‑B) study, measuring interleukin‑6 levels linked to astronaut bone loss. The demonstration, led by NASA’s Biological and Physical Sciences Division, aims to prove that commercial lab equipment can operate in low‑Earth orbit, potentially paving the way for automated, real‑time health monitoring on future deep‑space missions.
  • NASA has delivered a cellphone‑sized microplate reader to the International Space Station aboard the SpaceX Crew‑12 mission. The off‑the‑shelf device, part of the Commercially Enabled Rapid Space Science (CERISS) program, will enable in‑situ biological assays, providing real‑time data instead of waiting for sample return. Initially the reader will test bone‑loss research samples from the Microgravity Associated Bone Loss‑B (MABL‑B) study, measuring interleukin‑6 levels that may contribute to astronaut bone loss. The demonstration aims to prove that commercial lab equipment can operate in low Earth orbit, potentially paving the way for automated, advanced testing on future long‑duration missions.

Sources: